Literature DB >> 8226930

Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor.

M Maccarana1, B Casu, U Lindahl.   

Abstract

Experiments based on interaction in free solution between basic fibroblast growth factor (FGF-2) and saccharides related to heparin/heparan sulfate showed that the growth factor binds to heparin and to selectively glucosaminyl 6-O-desulfated heparin but poorly to iduronosyl 2-O-desulfated heparin. 2-O-sulfate groups thus are essential to the interaction, whereas 6-O-sulfates are not required nor do they interfere with FGF-2 binding. Comparison of various bound/nonbound oligosaccharides implicated a minimal pentasaccharide sequence for FGF-2 binding, with the structure: -hexuronic acid-glucosamine N-sulfate-hexuronic acid-glucosamine N-sulfate-iduronic acid 2-O-sulfate- (reducing terminus to the right). Such (overlapping) sequences are abundant in heparin, albeit heavily obscured by irrelevant O-sulfate groups, and occur also in heparan sulfate, with or without additional O-sulfates.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8226930

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  94 in total

Review 1.  Heparan sulfate: growth control with a restricted sequence menu.

Authors:  J T Gallagher
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  The C-terminal fragment of axon guidance molecule Slit3 binds heparin and neutralizes heparin's anticoagulant activity.

Authors:  Eduard Condac; Heather Strachan; Gerardo Gutierrez-Sanchez; Benjamin Brainard; Christina Giese; Christian Heiss; Darryl Johnson; Parastoo Azadi; Carl Bergmann; Ron Orlando; Charles T Esmon; Job Harenberg; Kelley Moremen; Lianchun Wang
Journal:  Glycobiology       Date:  2012-05-28       Impact factor: 4.313

3.  Screening for anticoagulant heparan sulfate octasaccharides and fine structure characterization using tandem mass spectrometry.

Authors:  Hicham Naimy; Nancy Leymarie; Joseph Zaia
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

4.  Directing the biological activities of heparan sulfate oligosaccharides using a chemoenzymatic approach.

Authors:  Yongmei Xu; Zhen Wang; Renpeng Liu; Arlene S Bridges; Xuefei Huang; Jian Liu
Journal:  Glycobiology       Date:  2011-08-11       Impact factor: 4.313

5.  Tumor cell and connective tissue cell interactions in human colorectal adenocarcinoma. Transfer of platelet-derived growth factor-AB/BB to stromal cells.

Authors:  C Sundberg; M Branting; B Gerdin; K Rubin
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

6.  Cell surface heparan sulfate promotes replication of Toxoplasma gondii.

Authors:  Joseph R Bishop; Brett E Crawford; Jeffrey D Esko
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 7.  Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery.

Authors:  Tobias Miller; Melissa C Goude; Todd C McDevitt; Johnna S Temenoff
Journal:  Acta Biomater       Date:  2013-10-09       Impact factor: 8.947

8.  Peptide- and protein-mediated assembly of heparinized hydrogels.

Authors:  Kristi L Kiick
Journal:  Soft Matter       Date:  2008-01-01       Impact factor: 3.679

Review 9.  Heparan sulfate 2-O-sulfotransferase (Hs2st) and mouse development.

Authors:  Valerie A Wilson; John T Gallagher; Catherine L R Merry
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

Review 10.  Heparan sulfate and heparin interactions with proteins.

Authors:  Maria C Z Meneghetti; Ashley J Hughes; Timothy R Rudd; Helena B Nader; Andrew K Powell; Edwin A Yates; Marcelo A Lima
Journal:  J R Soc Interface       Date:  2015-09-06       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.